Portfolio company
FDNA
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence phenotyping software to help clinicians and researchers identify rare diseases and genetic disorders in patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genorare
This company develops an encrypted artificial intelligence platform for hospitals and pharmaceutical firms to diagnose rare diseases using genomic and electronic health record data.
Nostos Genomics
The company develops an automated software platform for variant interpretation that helps genetic testing laboratories diagnose patients with rare diseases.
TMA Precision Health
This company provides a clinical decision support platform using genomic data and medical records to improve rare disease diagnosis for health systems and pharmaceutical partners.
DNA1
This company develops a platform for relating phenotype to genotype to accelerate discoveries in diagnostics, precision medicine, and genetics for healthcare organisations.
gMendel
This company develops AI-powered software and diagnostic tests for prenatal and newborn genetic disorder screening for hospitals, laboratories and health ministries.
Diagnoly
This company develops artificial intelligence software for prenatal ultrasound imaging to help healthcare professionals detect fetal abnormalities.
Citizen Health
This company develops a data platform that aggregates medical records and provides AI-driven health insights for patients with rare and complex conditions.
OpalMedica
The company develops machine learning software for primary care clinicians to help identify rare and underdiagnosed diseases in patients earlier.
